Thus, roles of GLP-1R and its agonists in CCA remain to be elucidated, not only for the appropriate management of DM in those patients but also to provide the opportunity for repurposing anti-diabetic drugs for CCA treatment27. This evidence concerns the gene GLP1R and cholangiocarcinoma.